Literature DB >> 19485297

Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.

Seong-Woo Kim1, Jaeryung Oh, In Kyung Oh, Kuhl Huh.   

Abstract

Retinal pigment epithelial tears may occur after photodynamic therapy (PDT) in various diseases. The authors report a case of a retinal pigment epithelial tear after half light intensity (300 mW/cm2) PDT in a large serous pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy. A 52-year-old woman with a large serous pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy in the left eye received her first PDT treatment using verteporfin with a spot size of 6,640 microm, a duration of 83 seconds, and half (300 mW/cm2) of the standard 600 mW/cm2 light intensity, where the delivered PDT light dose was only 25 J/cm2. Two weeks later, visual acuity improved to 20/30. However, a large crescent-shaped retinal pigment epithelial tear was found during fundus examination. Even 50% reduced light fluence PDT can produce a retinal pigment epithelial tear in pigment epithelial detachment associated with chronic atypical central serous chorioretinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19485297     DOI: 10.3928/15428877-20090430-14

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  15 in total

1.  Finasteride for chronic central serous chorioretinopathy.

Authors:  Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

2.  Photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Jay Kumar Chhablani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-06       Impact factor: 3.117

3.  The giant tear of retinal pigment epithelium following focal laser in central serous chorioretinopathy.

Authors:  Avadhesh Oli; Divya Balakrishnan
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep

4.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

5.  A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy.

Authors:  Lijun Zhou; Victor Chong; Kunbei Lai; Chuangxin Huang; Fabao Xu; Yajun Gong; Maimaitiaili Youlidaxi; Tao Li; Lin Lu; Chenjin Jin
Journal:  Lasers Med Sci       Date:  2019-02-02       Impact factor: 3.161

Review 6.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

7.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

8.  Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years.

Authors:  Yang Jae Kim; Si Yeol Kim; Seungmin Ha; Daruchi Moon; San Seong; Oh Woong Kwon; Han Sang Park
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

9.  Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.

Authors:  Ju Young Kim; Han Sang Park; Si Yeol Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-26       Impact factor: 3.117

Review 10.  Interventions for central serous chorioretinopathy: a network meta-analysis.

Authors:  Mahsa Salehi; Adam S Wenick; Hua Andrew Law; Jennifer R Evans; Peter Gehlbach
Journal:  Cochrane Database Syst Rev       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.